Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 18.3 | 9.3 | 18.1 | 4.0 | 2.0 | 0.3 | 0.0 |
| Revenue growth | 95.7% | -48.6% | 357.6% | 100.4% | 490.7% | | |
| Cost of goods sold | 106.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | -88.0 | 9.3 | 18.1 | 4.0 | 2.0 | 0.3 | 0.0 |
| Gross margin | -481.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Research and development | | 67.0 | 65.8 | 33.9 | 32.9 | 26.3 | 11.1 |
| General and administrative | 41.7 | 21.4 | 15.6 | 12.9 | 10.8 | 7.2 | 2.2 |
| EBIT | -88.0 | -79.1 | -63.2 | -42.8 | -41.7 | -33.2 | -13.3 |
| EBIT margin | -481.9% | -847.9% | -348.4% | -1079.3% | -2108.6% | -9916.7% | |
| Pre-tax income | -89.8 | -78.3 | -60.9 | -41.7 | -39.9 | -32.6 | -13.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -89.8 | -78.3 | -60.9 | -41.7 | -46.1 | -29.9 | -13.4 |
| Net margin | -491.7% | -839.0% | -335.7% | -1050.5% | -2329.3% | -8933.7% | |
| |
| Diluted EPS | ($2.91) | ($3.50) | ($3.35) | ($2.60) | ($17.82) | ($95.87) | ($53.11) |
| Shares outstanding (diluted) | 30.9 | 22.4 | 18.2 | 16.0 | 2.6 | 0.3 | 0.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|